A group of children and adults with hypothalamic obesity receiving setmelanotide for 1 year had nearly a 20% greater BMI ...

Waist-to-height ratio should be used in conjunction with BMI to assess overweight and obesity in children and adolescents, a ...

The prevalence of metabolic dysfunction–associated steatotic liver disease, chronic kidney disease, and obstructive sleep ...

A new study from Lund University in Malmö, Sweden, revealed that waist circumference is a stronger risk indicator for obesity ...

Topline data were announced from a phase 3 trial evaluating setmelanotide for the treatment of acquired hypothalamic obesity.

Johns Hopkins University-led research has found that obesity, particularly severe obesity, is strongly associated with the ...

Cross-sectional studies and Mendelian randomization show that insulin resistance and chronic inflammation mediate the ...

Stifel analysts were bullish on the data, which showed a 16.5% drop in body-mass index among patients with damage to the ...

In bustling Mumbai, childhood obesity is quietly snowballing into full-blown health crisis; government survey flagged that 8 ...

Findings showed patients on setmelanotide saw a mean BMI reduction of 16.5% from baseline ... for the treatment of acquired hypothalamic obesity. Setmelanotide, a melanocortin-4 receptor agonist ...

Rhythm's Phase 3 trial shows setmelanotide significantly reduced BMI in rare hypothalamic obesity without new safety concerns over 52 weeks.